Twist Bioscience CEO Emily Leproust disposes of common shares worth $2.5 million
TWST•CEO exercises options and sells shares
- Twist Bioscience CEO Emily M. Leproust exercised stock options for 19,952 shares on Aug. 12, 2026 at USD 26.66.
- She sold 19,952 shares the same day at a weighted average USD 125.08, leaving direct holdings of 818,938 shares.
